Search Results - "Chackerian, Bryce"

Refine Results
  1. 1

    Why HIV virions have low numbers of envelope spikes: implications for vaccine development by Schiller, John, Chackerian, Bryce

    Published in PLoS pathogens (01-08-2014)
    “…  [...]by evolving an escape mechanism that relies on ignorance of the virions by the humoral immune system, HPVs have not evolved strategies to evade…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Vaccine strategies for lowering LDL by immunization against proprotein convertase subtilisin/kexin type 9 by Chackerian, Bryce, Remaley, Alan

    Published in Current opinion in lipidology (01-08-2016)
    “…mAbs targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) have the potential to become groundbreaking therapies for the treatment of…”
    Get full text
    Journal Article
  4. 4

    Cell-Specific Delivery of Diverse Cargos by Bacteriophage MS2 Virus-like Particles by Ashley, Carlee E, Carnes, Eric C, Phillips, Genevieve K, Durfee, Paul N, Buley, Mekensey D, Lino, Christopher A, Padilla, David P, Phillips, Brandy, Carter, Mark B, Willman, Cheryl L, Brinker, C. Jeffrey, Caldeira, Jerri do Carmo, Chackerian, Bryce, Wharton, Walker, Peabody, David S

    Published in ACS nano (26-07-2011)
    “…Virus-like particles (VLPs) of bacteriophage MS2 possess numerous features that make them well-suited for use in targeted delivery of therapeutic and imaging…”
    Get full text
    Journal Article
  5. 5

    Factors That Govern the Induction of Long-Lived Antibody Responses by Chackerian, Bryce, Peabody, David S

    Published in Viruses (07-01-2020)
    “…The induction of long-lasting, high-titer antibody responses is critical to the efficacy of many vaccines. The ability to produce durable antibody responses is…”
    Get full text
    Journal Article
  6. 6

    Virus-like particle based vaccines for Alzheimer disease by Chackerian, Bryce

    Published in Human vaccines (01-11-2010)
    “…Vaccines targeting the amyloid-β (Aβ) peptide have promise as immunotherapies for the treatment of Alzheimer disease (AD). Human trials of a first generation…”
    Get full text
    Journal Article
  7. 7
  8. 8

    An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein by Jelínková, Lucie, Jhun, Hugo, Eaton, Allison, Petrovsky, Nikolai, Zavala, Fidel, Chackerian, Bryce

    Published in npj vaccines (21-01-2021)
    “…A malaria vaccine that elicits long-lasting protection and is suitable for use in endemic areas remains urgently needed. Here, we assessed the immunogenicity…”
    Get full text
    Journal Article
  9. 9

    A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2 by Tumban, Ebenezer, Peabody, Julianne, Peabody, David S, Chackerian, Bryce

    Published in PloS one (17-08-2011)
    “…Current human papillomavirus (HPV) vaccines that are based on virus-like particles (VLPs) of the major capsid protein L1 largely elicit HPV type-specific…”
    Get full text
    Journal Article
  10. 10

    VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus by Tumban, Ebenezer, Peabody, Julianne, Tyler, Mitchell, Peabody, David S, Chackerian, Bryce

    Published in PloS one (19-11-2012)
    “…Virus-like Particles (VLPs) display can be used to increase the immunogenicity of heterologous antigens. Here, we report the use of a bacteriophage MS2-based…”
    Get full text
    Journal Article
  11. 11

    A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine by Janitzek, Christoph M., Peabody, Julianne, Thrane, Susan, H. R. Carlsen, Philip, G. Theander, Thor, Salanti, Ali, Chackerian, Bryce, A. Nielsen, Morten, Sander, Adam F.

    Published in Scientific reports (27-03-2019)
    “…In Africa, cervical cancer and placental malaria (PM) are a major public health concern. There is currently no available PM vaccine and the marketed Human…”
    Get full text
    Journal Article
  12. 12

    RNA Phage VLP-Based Vaccine Platforms by Peabody, David S, Peabody, Julianne, Bradfute, Steven B, Chackerian, Bryce

    Published in Pharmaceuticals (Basel, Switzerland) (04-08-2021)
    “…Virus-like particles from a variety of RNA bacteriophages have turned out to be useful platforms for delivery of vaccine antigens in a highly immunogenic…”
    Get full text
    Journal Article
  13. 13

    Applying lessons from human papillomavirus vaccines to the development of vaccines against Chlamydia trachomatis by Frietze, Kathryn M, Lijek, Rebeccah, Chackerian, Bryce

    Published in Expert review of vaccines (02-11-2018)
    “…Chlamydia trachomatis (Ct), the most common bacterial sexually transmitted infection (STI), leads to pelvic inflammatory disease, infertility, and ectopic…”
    Get full text
    Journal Article
  14. 14

    Pathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses by Frietze, Kathryn M, Pascale, Juan M, Moreno, Brechla, Chackerian, Bryce, Peabody, David S

    Published in PloS one (02-02-2017)
    “…Identifying the targets of antibody responses during infection is important for designing vaccines, developing diagnostic and prognostic tools, and…”
    Get full text
    Journal Article
  15. 15

    A vaccine targeting the L9 epitope of the malaria circumsporozoite protein confers protection from blood-stage infection in a mouse challenge model by Jelínková, Lucie, Flores-Garcia, Yevel, Shapiro, Sarah, Roberts, Bryce T., Petrovsky, Nikolai, Zavala, Fidel, Chackerian, Bryce

    Published in npj vaccines (08-03-2022)
    “…Pre-erythrocytic malaria vaccines that induce high-titer, durable antibody responses can potentially provide protection from infection. Here, we engineered a…”
    Get full text
    Journal Article
  16. 16

    Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform by Caldeira, Jerri, Bustos, Jeremiah, Peabody, Julianne, Chackerian, Bryce, Peabody, David S

    Published in PloS one (30-10-2015)
    “…The possibility of a contraceptive vaccine targeting human chorionic gonadotropin has long been recognized, but never fully realized. Here we describe an…”
    Get full text
    Journal Article
  17. 17

    Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9 by Kunda, Nitesh K., Peabody, Julianne, Zhai, Lukai, Price, Dominique N., Chackerian, Bryce, Tumban, Ebenezer, Muttil, Pavan

    Published in Human vaccines & immunotherapeutics (03-08-2019)
    “…High-risk human papillomavirus (HPV) types are responsible for nearly all cases of cervical cancers. Cervarix® and Gardasil® 9 are the current prophylactic…”
    Get full text
    Journal Article
  18. 18

    Minimal Determinants for Lifelong Antiviral Antibody Responses in Mice from a Single Exposure to Virus-like Immunogens at Low Doses by Wholey, Wei-Yun, Meyer, Alexander R, Yoda, Sekou-Tidiane, Chackerian, Bryce, Zikherman, Julie, Cheng, Wei

    Published in Vaccines (Basel) (01-04-2024)
    “…The durability of an antibody (Ab) response is highly important for antiviral vaccines. However, due to the complex compositions of natural virions, the…”
    Get full text
    Journal Article
  19. 19

    Engineering an Antibody V Gene-Selective Vaccine by Ronsard, Larance, Yousif, Ashraf S, Peabody, Julianne, Okonkwo, Vintus, Devant, Pascal, Mogus, Alemu Tekewe, Barnes, Ralston M, Rohrer, Daniel, Lonberg, Nils, Peabody, David, Chackerian, Bryce, Lingwood, Daniel

    Published in Frontiers in immunology (09-09-2021)
    “…The ligand-binding surface of the B cell receptor (BCR) is formed by encoded and non-encoded antigen complementarity determining regions (CDRs). Genetically…”
    Get full text
    Journal Article
  20. 20

    Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display by Crossey, Erin, Frietze, Kathryn, Narum, David L, Peabody, David S, Chackerian, Bryce

    Published in PloS one (06-07-2015)
    “…We have developed a peptide display platform based on VLPs of the RNA bacteriophage MS2 that combines the high immunogenicity of VLP display with affinity…”
    Get full text
    Journal Article